Rio Olympics end with big TV ad spending tallies, but pharma marketers finish in middle of pack

Pharma companies finished in the middle of the pack of blockbuster TV advertisers during the Olympic Games in Rio. While total TV spending was a whopping $1.18 billion, pharma only contributed $45 million during the 17-day event, according to real time TV ad tracker

The top spending pharma brand was Novo Nordisk’s GLP-1 diabetes treatment Victoza at $9.2 million, followed by two Pfizer drugs, the pain medication Lyrica at $9.1 million and the anti-inflammatory Xeljanz at $5.7 million. That compares to top spending consumer brands such as Chrysler, which spent $25 million on one commercial along and $15.2 million on another, or Samsung, which spent $17.1 million on one ad and $12 million on another one.



Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.


Overall, 20 pharma brands and companies ran 293 TV ads during Olympic coverage, on channels including NBC primetime and cable outlets NBC Sports, CNBC, MSNBC and USA Network.

Merck, Mylan and Pfizer ran corporate or disease awareness commercials, while some of the other pharma brands airing ads included Bayer and Johnson & Johnson's anticoagulant Xarelto and Lundbeck and Takeda’s antidepressant Trintellix.

However, being a middle-of-the-road advertiser in these Games may not have been a bad move. Bloomberg reported that Olympic Games TV viewership was down 17% from the London Games in 2012, accounting for the first Summer Games’ decline in ratings since 2000.

- look up ads on iSpot
- read more on Bloomberg

Special Report: The top 10 advertisers in Big Pharma | The top 10 most-advertised prescription drug brands

Related Articles:
Going for emotion: Pharma takes a page from consumer marketers for Olympic ads
Celgene brings on Olympic swimmer to help Otezla lap psoriasis rivals
Pharma brings the heat in July as TV ad spending soars
Valeant, AstraZeneca played the Super Bowl ad game, but did they win?

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.